Osteopontin in Bone Metabolism and Bone Diseases

192Citations
Citations of this article
224Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Osteopontin (OPN), a secreted phosphoprotein, is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family of cell matrix proteins and participates in many biological activities. Studies have shown that OPN plays a role in bone metabolism and homeostasis. OPN not only is an important factor in neuron-mediated and endocrine-regulated bone mass, but also is involved in biological activities such as proliferation, migration, and adhesion of several bone-related cells, including bone marrow mesenchymal stem cells, hematopoietic stem cells, osteoclasts, and osteoblasts. OPN has been demonstrated to be closely related to the occurrence and development of many bone-related diseases, such as osteoporosis, rheumatoid arthritis, and osteosarcoma. As expected, the functions of OPN in the bone have become a research hotspot. In this article, we try to decipher the mechanism of OPN-regulated bone metabolism and bone diseases.

Author supplied keywords

Cite

CITATION STYLE

APA

Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., & Zhou, Y. (2020, January 30). Osteopontin in Bone Metabolism and Bone Diseases. Medical Science Monitor. International Scientific Information, Inc. https://doi.org/10.12659/MSM.919159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free